RxDoctor Payments Data

Nani Moss, MD

Urogynecology and Reconstructive Pelvic Surgery · Skokie, ILNPI 1730574807

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (53.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Boston Scientific at 43.0% of the total. Reporting peaked in 2024 at $1,684 and has fallen 91.5% since, to $143 in 2025.

$4,709in general payments, 2019–2025

Across 54 payments — averaging $87.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Axonics, Inc.$2K
  • Coloplast$403
  • Medtronic$284
  • Escala Medical Inc.$168
  • Urovant Sciences Inc$119
  • plus $186 from 4 others

What the payments were for

  • Travel & lodging$2,01843%
  • Food & beverage$2,50153%
  • Education$1904%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific21$2,024
Axonics, Inc.14$1,525
Coloplast5$403
Medtronic(2 entities)6$284
Escala Medical Inc.1$168
Urovant Sciences Inc1$119
Pfizer1$85
AbbVie(2 entities)2$50
Convatec Inc.2$35
Hollister Incorporated1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,709 in reported general payments places this provider in the 60th percentile of 62 urogynecology and reconstructive pelvic surgery providers in Illinois.

See all urogynecology and reconstructive pelvic surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$81,100
Medicare patients
160
Services billed
991

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron229$160,222
GemtesaVibegron109$73,503
Trospium Chloride ErTrospium Chloride71$14,877
Estradiol266$13,735
Solifenacin Succinate282$13,463
Methenamine Hippurate89$7,708
Tolterodine Tartrate ErTolterodine Tartrate23$2,304
Trospium Chloride31$2,267
Trimethoprim23$1,333
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst55$466
Clobetasol Propionate19$396
Oxybutynin Chloride ErOxybutynin Chloride15$306
Ibuprofen42$211
Fesoterodine Fumarate ErFesoterodine Fumarate14$195
Cephalexin22$78

Paid to pharmacies, not to this prescriber.

Other urogynecology and reconstructive pelvic surgery in Skokie

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →